Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

MLA

Dorard, Coralie, et al. “Expression of a Mutant HSP110 Sensitizes Colorectal Cancer Cells to Chemotherapy and Improves Disease Prognosis.” Nature Medicine, vol. 17, no. 10, Sept. 2011, pp. 1283–89. EBSCOhost, https://doi.org/10.1038/nm.2457.

APA

Dorard, C., de Thonel, A., Collura, A., Marisa, L., Svrcek, M., Lagrange, A., Jego, G., Wanherdrick, K., Joly, A. L., Buhard, O., Gobbo, J., Penard-Lacronique, V., Zouali, H., Tubacher, E., Kirzin, S., Selves, J., Milano, G., Etienne-Grimaldi, M.-C., Bengrine-Lefèvre, L., … Duval, A. (2011). Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. Nature Medicine, 17(10), 1283–1289. https://doi.org/10.1038/nm.2457

Chicago

Dorard, Coralie, Aurélie de Thonel, Ada Collura, Laetitia Marisa, Magali Svrcek, Anaïs Lagrange, Gaetan Jego, et al. 2011. “Expression of a Mutant HSP110 Sensitizes Colorectal Cancer Cells to Chemotherapy and Improves Disease Prognosis.” Nature Medicine 17 (10): 1283–89. doi:10.1038/nm.2457.